113 related articles for article (PubMed ID: 11992567)
1. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.
Shibata N; Ohnuma T; Takahashi T; Baba H; Ishizuka T; Ohtsuka M; Ueki A; Nagao M; Arai H
Am J Med Genet; 2002 May; 114(4):436-9. PubMed ID: 11992567
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
[TBL] [Abstract][Full Text] [Related]
6. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138
[TBL] [Abstract][Full Text] [Related]
7. CD14 receptor polymorphism and Alzheimer's disease risk.
Combarros O; Infante J; Rodríguez E; Llorca J; Peña N; Fernández-Viadero C; Berciano J
Neurosci Lett; 2005 May 20-27; 380(1-2):193-6. PubMed ID: 15854776
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.
Ravaglia G; Paola F; Maioli F; Martelli M; Montesi F; Bastagli L; Bianchin M; Chiappelli M; Tumini E; Bolondi L; Licastro F
Exp Gerontol; 2006 Jan; 41(1):85-92. PubMed ID: 16297587
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
Pola R; Flex A; Gaetani E; Proia AS; Papaleo P; Di Giorgio A; Straface G; Pecorini G; Serricchio M; Pola P
Exp Gerontol; 2004 Aug; 39(8):1249-52. PubMed ID: 15288699
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
11. Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.
Bagli M; Papassotiropoulos A; Knapp M; Jessen F; Luise Rao M; Maier W; Heun R
Neurosci Lett; 2000 Apr; 283(2):109-12. PubMed ID: 10739887
[TBL] [Abstract][Full Text] [Related]
12. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.
Aulisa L; Papaleo P; Pola E; Angelini F; Aulisa AG; Tamburrelli FC; Pola P; Logroscino CA
Spine (Phila Pa 1976); 2007 Nov; 32(24):2700-2. PubMed ID: 18007247
[TBL] [Abstract][Full Text] [Related]
13. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
14. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.
Ma SL; Tang NL; Lam LC; Chiu HF
Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease.
Zhang Y; Hayes A; Pritchard A; Thaker U; Haque MS; Lemmon H; Harris J; Cumming A; Lambert JC; Chartier-Harlin MC; St Clair D; Iwatsubo T; Mann DM; Lendon CL
Neurosci Lett; 2004 May; 362(2):99-102. PubMed ID: 15193763
[TBL] [Abstract][Full Text] [Related]
16. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
17. Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease.
Chuo LJ; Sheu WH; Pai MC; Kuo YM
Dement Geriatr Cogn Disord; 2007; 23(4):251-7. PubMed ID: 17310123
[TBL] [Abstract][Full Text] [Related]
18. Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease.
Nishimura M; Sakamoto T; Kaji R; Kawakami H
Neurosci Lett; 2004 Sep; 368(2):140-3. PubMed ID: 15351436
[TBL] [Abstract][Full Text] [Related]
19. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
